NR3C2 and leiomyoma: (Armanini et al., 2018) Using an in vitro model, Isobe et al. reported proliferation of rat leiomyoma cells with separate treatments of aldosterone and angiotensin II; however, treatment with a mineralocorticoid receptor antagonist suppressed this activity.